Financhill
Back

New York Times Vs. Cidara Therapeutics Industry Stock Comparison

Buy
73

NYT
New York Times

Last Price:
$60.64
Seasonality Move:
-1.02%
Buy
77

CDTX
Cidara Therapeutics

Last Price:
$63.02
Seasonality Move:
2.01%
Buy
73
New York Times (NYT) is a Buy

Is New York Times a Buy, Sell or Hold?

  • The current New York Times [NYT] share price is $58.01. The Score for NYT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NYT Stock Price Chart

What is New York Times's stock price today?

  • The New York Times share price today is $58.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $62.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.61 Buy
Relative Strength Index (14 RSI): 60.3 Buy
Chaikin Money Flow: 953834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.08 - 57.12) Buy
Bollinger Bands (100): (50.11 - 56.41) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.72 Buy
Relative Strength Index (14 RSI): 66.1 Buy
Chaikin Money Flow: -71329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.74 - 63.84) Buy
Bollinger Bands (100): (16.87 - 51.01) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.61 Buy
20-day SMA: 54.31 Buy
50-day SMA: 55.14 Buy
200-day SMA: 52.86 Buy
8-day EMA: 53.41 Buy
20-day EMA: 37.43 Buy
50-day EMA: 19.8 Buy
200-day EMA: 5.77 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.11 Sell
20-day SMA: 61.15 Buy
50-day SMA: 46.89 Buy
200-day SMA: 27.08 Buy
8-day EMA: 58.14 Buy
20-day EMA: 41.46 Buy
50-day EMA: 22.13 Buy
200-day EMA: 6.48 Buy

New York Times Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.

New York Times Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):